The Parker institute funds clinical trials for cancer treatments -- including for melanoma and pancreatic cancer -- and partners with cancer research centers, drug manufacturers and biotech companies to advance immunotherapy research. The institute was formed in 2016 with $250 million from the Parker Foundation.
Brainstorm Health: Pharma CEOs' Midterm Money, Parker Institute Investment, Merck Pfizer Combo Treatment
Silicon Valley's Tech Elite Zoom in on Crispr
Documentaries, videos and podcasts
The Parker Institute for Cancer Immunotherapy: An Unprecedented Research Collaboration
November 15, 2016